• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院炎症性肠病患者的尿路感染:10 年经验。

Urinary tract infections in hospitalized inflammatory bowel disease patients: a 10-year experience.

机构信息

Inserm, U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Vandoeuvre-Les-Nancy, France.

出版信息

Inflamm Bowel Dis. 2012 Apr;18(4):697-702. doi: 10.1002/ibd.21777. Epub 2011 Jul 7.

DOI:10.1002/ibd.21777
PMID:21739531
Abstract

BACKGROUND

Cystitis is the most common genitourinary complication in Crohn's disease (CD). We assessed the prevalence of and risk factors for urinary tract infections (UTI) in inflammatory bowel diseases (IBD).

METHODS

Among the 1173 IBD patients of the "Nancy IBD cohort" seen between January 1, 2000 and December 31, 2009, 56 hospitalized patients had 76 documented UTI. Prevalence of UTI in IBD was calculated using rates of UTI among non-IBD patients hospitalized during the same period. The cases were compared to 175 matched IBD patients without UTI hospitalized during the same period to identify risk factors for UTI.

RESULTS

Prevalence of UTI was 4% in IBD patients versus 3.3% in non-IBD patients (P = 0.1). Prevalence of UTI was 4.5% and 2.1% in ulcerative colitis (UC) and CD patients, respectively (P = 0.6). Risk factors for UTI in CD patients were perianal disease (odds ratio [OR] = 2.28, 95% confidence interval [CI], 1.06-4.89; P = 0.04) and colonic disease (OR = 2.42, 95% CI, 1.05-5.58; P = 0.04). Male gender (OR = 0.38, 95% CI, 0.17-0.85, P = 0.02) and noncomplicated behavior (OR = 0.26, 95% CI, 0.11-0.60, P = 0.002) were protective factors against UTI in CD. In UC patients, age over 40 years (OR = 9.59, 95% CI, 1.93-47.74; P = 0.006) and disease duration over 11 months (OR = 10.77, 95% CI, 1.68-68.89, P = 0.01) were risk factors for UTI. Male gender was negatively associated with UTI (OR = 0.04, 95% CI, 0.01-0.36, P = 0.00006).

CONCLUSIONS

Hospitalized IBD patients are not at increased risk of UTI. Risk factors for UTI include perianal disease and colonic disease in CD and age and longer disease duration in UC.

摘要

背景

膀胱炎是克罗恩病(CD)最常见的泌尿生殖系统并发症。我们评估了炎症性肠病(IBD)患者尿路感染(UTI)的患病率和危险因素。

方法

在 2000 年 1 月 1 日至 2009 年 12 月 31 日期间,“南希 IBD 队列”中的 1173 名 IBD 患者中,56 名住院患者有 76 例有记录的 UTI。使用同期住院的非 IBD 患者中 UTI 的发生率计算 IBD 患者中 UTI 的患病率。将这些病例与同期住院的 175 例无 UTI 的匹配 IBD 患者进行比较,以确定 UTI 的危险因素。

结果

IBD 患者的 UTI 患病率为 4%,而非 IBD 患者为 3.3%(P=0.1)。溃疡性结肠炎(UC)和 CD 患者的 UTI 患病率分别为 4.5%和 2.1%(P=0.6)。CD 患者 UTI 的危险因素包括肛周疾病(比值比[OR]=2.28,95%置信区间[CI],1.06-4.89;P=0.04)和结肠疾病(OR=2.42,95%CI,1.05-5.58;P=0.04)。男性(OR=0.38,95%CI,0.17-0.85,P=0.02)和非复杂性行为(OR=0.26,95%CI,0.11-0.60,P=0.002)是 CD 患者 UTI 的保护因素。在 UC 患者中,年龄大于 40 岁(OR=9.59,95%CI,1.93-47.74;P=0.006)和疾病持续时间超过 11 个月(OR=10.77,95%CI,1.68-68.89,P=0.01)是 UTI 的危险因素。男性与 UTI 呈负相关(OR=0.04,95%CI,0.01-0.36,P=0.00006)。

结论

住院 IBD 患者发生 UTI 的风险并未增加。UTI 的危险因素包括 CD 中的肛周疾病和结肠疾病,以及 UC 中的年龄和较长的疾病持续时间。

相似文献

1
Urinary tract infections in hospitalized inflammatory bowel disease patients: a 10-year experience.住院炎症性肠病患者的尿路感染:10 年经验。
Inflamm Bowel Dis. 2012 Apr;18(4):697-702. doi: 10.1002/ibd.21777. Epub 2011 Jul 7.
2
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.炎症性肠病的癌症风险:一项为期 6 年的前瞻性多中心巢式病例对照 IG-IBD 研究。
Inflamm Bowel Dis. 2020 Feb 11;26(3):450-459. doi: 10.1093/ibd/izz155.
3
Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009.炎症性肠病患者的尿路结石与尿路感染:对2006年至2009年间美国急诊科就诊情况的综述
Urology. 2015 Apr;85(4):764-70. doi: 10.1016/j.urology.2014.12.011. Epub 2015 Feb 7.
4
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.在一项前瞻性多中心巢式病例对照IG-IBD研究中,炎症性肠病表型作为癌症的风险因素
J Crohns Colitis. 2016 Aug;10(8):913-24. doi: 10.1093/ecco-jcc/jjw048. Epub 2016 Mar 1.
5
Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.炎症性肠病诊断后第一年与感染相关的住院情况。
J Dig Dis. 2016 Sep;17(9):610-617. doi: 10.1111/1751-2980.12397.
6
Factors associated with readmissions and outcomes of patients hospitalized for inflammatory bowel disease.与炎症性肠病患者住院再入院和结局相关的因素。
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1897-1904.e1. doi: 10.1016/j.cgh.2014.02.042. Epub 2014 Mar 26.
7
Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.炎症性肠病住院成人的自杀行为:美国全国性分析。
Inflamm Bowel Dis. 2017 Dec 19;24(1):25-34. doi: 10.1093/ibd/izx005.
8
[Community-acquired urinary tract infections in the internal and nephrology ward: etiology and selected risk factors].[内科与肾内科病房的社区获得性尿路感染:病因及某些危险因素]
Przegl Lek. 2016;73(11):824-9.
9
The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.炎症性肠病患者患结直肠癌的风险:一项基于韩国医院的队列研究。
Scand J Gastroenterol. 2015 Feb;50(2):188-96. doi: 10.3109/00365521.2014.989538. Epub 2014 Dec 17.
10
Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.生物制剂时代基于人群的炎症性肠病前瞻性队列研究:疾病进程及严重程度的预测因素
J Gastroenterol Hepatol. 2015 Sep;30(9):1346-53. doi: 10.1111/jgh.12967.

引用本文的文献

1
Exploring Factors Affecting Acceptance of Fecal Microbiota Transplantation for Patients with Recurrent Urinary Tract Infections: a Descriptive Qualitative Study.探索影响复发性尿路感染患者接受粪便微生物群移植的因素:一项描述性定性研究。
Patient Prefer Adherence. 2024 Jun 17;18:1257-1269. doi: 10.2147/PPA.S452328. eCollection 2024.
2
Phylogrouping and characterization of isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran.从伊朗炎症性肠病发作患者的结肠活检组织和粪便样本中分离出的菌株进行系统发育分组和特征分析。
Front Med (Lausanne). 2022 Aug 29;9:985300. doi: 10.3389/fmed.2022.985300. eCollection 2022.
3
Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract Infection.
接受尿路感染治疗的炎症性肠病患者的不良临床结局
J Clin Med. 2022 Mar 1;11(5):1359. doi: 10.3390/jcm11051359.
4
Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study.非裔美国人和白种人炎症性肠病患者的尿表现:一项回顾性队列研究。
BMC Urol. 2022 Jan 4;22(1):1. doi: 10.1186/s12894-021-00951-z.
5
Genetic risk factors for serious infections in inflammatory bowel diseases.炎症性肠病严重感染的遗传风险因素。
Scand J Gastroenterol. 2017 May;52(5):570-576. doi: 10.1080/00365521.2017.1286381. Epub 2017 Feb 5.
6
Metabolomic profiles are gender, disease and time specific in the interleukin-10 gene-deficient mouse model of inflammatory bowel disease.代谢组学谱在白细胞介素-10 基因缺陷的炎症性肠病小鼠模型中具有性别、疾病和时间特异性。
PLoS One. 2013 Jul 9;8(7):e67654. doi: 10.1371/journal.pone.0067654. Print 2013.